We are live on ! Find out more
GP

Geneva Partners Portfolio holdings

AUM $375M
1-Year Est. Return 131.24%
This Fund
S&P 500
This Quarter Est. Return
+7.16%
1 Year Est. Return
+131.24%
3 Year Est. Return
+400.69%
5 Year Est. Return
+687.84%
10 Year Est. Return
AUM
$145M
AUM Growth
+$16.5M
Cap. Flow
+$9.04M
Cap. Flow %
6.24%
Top 10 Hldgs %
37.21%
Holding
80
New
11
Increased
29
Reduced
25
Closed
13

Top Buys

Rank Stock Value
1
VYM icon
Vanguard High Dividend Yield ETF
VYM
+$6.15M
2
DOV icon
Dover
DOV
+$2.66M
3
QCOM icon
Qualcomm
QCOM
+$2.08M
4
BABA icon
Alibaba
BABA
+$1.21M
5
EME icon
Emcor
EME
+$700K

Sector Composition

Rank Sector Weight
1 Miscellaneous 27.5%
2 Healthcare 13.41%
3 Industrials 11.25%
4 Communication Services 10.71%
5 Consumer Discretionary 10.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TMO icon
26
Thermo Fisher Scientific
TMO
$225B
$2.31M 1.6%
7,125
-85
-1% -$25.8K
QCOM icon
27
Qualcomm
QCOM
$194B
$2.19M 1.51%
+24,830
New +$2.08M
ARE icon
28
Alexandria Real Estate Equities
ARE
$8.8B
$2.16M 1.49%
13,395
-440
-3% -$69.4K
DVY icon
29
iShares Select Dividend ETF
DVY
$23.6B
$1.83M 1.26%
17,309
+468
+3% +$48.2K
IJH icon
30
iShares Core S&P Mid-Cap ETF
IJH
$124B
$1.7M 1.18%
41,375
+190
+0.5% +$7.53K
LMT icon
31
Lockheed Martin
LMT
$121B
$1.58M 1.09%
4,069
-600
-13% -$230K
HON icon
32
Honeywell
HON
$64.1B
$1.5M 1.03%
8,981
+535
+6% +$87.5K
SPY icon
33
State Street SPDR S&P 500 ETF Trust
SPY
$808B
$1.48M 1.02%
4,597
+1,385
+43% +$426K
AMGN icon
34
Amgen
AMGN
$204B
$1.46M 1.01%
6,050
-250
-4% -$55.1K
V icon
35
Visa
V
$692B
$1.43M 0.99%
7,611
+481
+7% +$86.7K
CWB icon
36
State Street SPDR Bloomberg Convertible Securities ETF
CWB
$5.63B
$1.42M 0.98%
25,581
+399
+2% +$21.5K
CME icon
37
CME Group
CME
$99.1B
$1.41M 0.97%
7,041
-9,762
-58% -$2M
GDX icon
38
VanEck Gold Miners ETF
GDX
$29.5B
$1.4M 0.97%
47,958
-6,075
-11% -$166K
BABA icon
39
Alibaba
BABA
$272B
$1.37M 0.94%
+6,440
New +$1.21M
IUSV icon
40
iShares Core S&P US Value ETF
IUSV
$27.7B
$1.3M 0.9%
20,667
-441
-2% -$26.6K
RVTY icon
41
Revvity
RVTY
$13.9B
$1.25M 0.86%
12,873
DHR icon
42
Danaher
DHR
$141B
$1.24M 0.85%
9,092
+170
+2% +$21.5K
WM icon
43
Waste Management
WM
$85.3B
$1.09M 0.75%
9,537
-400
-4% -$45.2K
AMT icon
44
American Tower
AMT
$82.9B
$1.05M 0.73%
4,587
-410
-8% -$89.3K
TDG icon
45
TransDigm Group
TDG
$63B
$1.04M 0.72%
1,866
-1,561
-46% -$854K
CHDN icon
46
Churchill Downs
CHDN
$5.85B
$907K 0.63%
13,220
-4,920
-27% -$320K
FREL icon
47
Fidelity MSCI Real Estate Index ETF
FREL
$1.44B
$740K 0.51%
26,560
+3,717
+16% +$103K
CCI icon
48
Crown Castle
CCI
$32.2B
$730K 0.5%
5,133
-175
-3% -$23.9K
PAYX icon
49
Paychex
PAYX
$41.2B
$716K 0.49%
8,423
-257
-3% -$21.7K
FISV
50
Fiserv Inc
FISV
$27.4B
$708K 0.49%
6,125
+2,885
+89% +$319K

Similar funds

Geneva Partners's Q4 2019 Portfolio in Review

As of Q4 2019, Geneva Partners held 80 positions worth $145M, up 13% from $128M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Geneva Partners deployed $9.04M of net new capital in Q4 2019, opening 11 new positions and adding to 29 existing holdings. Its largest new stake was Vanguard High Dividend Yield ETF: 67,835 shares worth $6.36M.

By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 23% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was CME Group, an estimated $2M trimmed.

  • Geneva Partners's largest Q4 2019 buy was Vanguard High Dividend Yield ETF: 67,835 shares worth $6.36M.
  • Geneva Partners added most to SPDR Gold Trust in Q4 2019, an estimated $651K increase.
  • Geneva Partners's biggest Q4 2019 reduction was CME Group, cutting an estimated $2M.
  • Geneva Partners fully exited Chipotle Mexican Grill in Q4 2019, selling an estimated $1.33M.
  • Geneva Partners's ten largest holdings make up 37% of its $145M portfolio in Q4 2019.
  • Geneva Partners opened 11 new positions and closed 13 in Q4 2019.
  • Geneva Partners's portfolio value rose 13% quarter-over-quarter to $145M.

Based on Geneva Partners's 13F filing for Q4 2019, filed 4 Feb 2020.